Physician profile
Kyndra P Wright
NPI 1376045963
$1,687.96
in general payments reported to CMS, 2019-2025
20 companies · $18.62 in 2025
The $18.62 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $548 · 2022: $466 · 2023: $408 · 2024: $248 · 2025: $18.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612 · Education: $61.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.20 |
| Education | $61.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $347.05 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $239.17 | 2021-2025 | Trintellix |
| Astellas Pharma US INC | $222.83 | 2021-2024 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $168.77 | 2021-2024 | Trulance |
| Aspira Women'S Health INC | $131.35 | 2021 | |
| Mayne Pharma Commercial LLC | $105.27 | 2021-2022 | |
| Amgen INC. | $73.51 | 2021-2024 | Evenity, Prolia |
| Pfizer INC. | $63.94 | 2022-2024 | |
| Hologic Sales and Service, LLC | $61.76 | 2022-2023 | Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $42.70 | 2023 | Myfembree |
| Organon LLC | $38.70 | 2022-2023 | Nexplanon |
| Shield Therapeutics INC | $28.88 | 2023 | Accrufer |
| Therapeuticsmd, INC. | $28.55 | 2021-2022 | |
| Scynexis, INC. | $26.89 | 2022 | |
| Roche Diagnostics Corporation | $24.22 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $19.83 | 2021 | |
| Myovant Sciences INC. | $19.28 | 2022 | |
| Evofem Biosciences, INC. | $19.20 | 2022 | |
| Mylan Pharmaceuticals INC. | $13.09 | 2022 | |
| Avion Pharmaceuticals | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyndra Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.